Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Ortoma

13,7

 

SEK

 

-0,36 %

Mindre end 1K følgere

ORT B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Sammenligne
-0,36%
+70,4%
+62,32%
+47,63%
+38,38%
+75,64%
-30,89%
-57,44%
+347,72%

Ortoma develops surgical systems for implant surgery. The technology is based on 3D and is used to plan and position implants such as hip, knee, and back surgery. The vision is to facilitate the work for orthopaedic surgeons and increase the efficiency in each surgery case. A major part of the business is research and development. The company is based in Gothenburg.

Læs mere
Markedsværdi
508,05 mio. SEK
Aktieomsætning
150,71 t SEK
Omsætning
49,11 mio.
EBIT %
-14,44 %
P/E
-
Udbytteafkast, %
-
Finanskalender
30.7
2025

Delårsrapport Q2'25

5.11
2025

Delårsrapport Q3'25

26.2
2026

Årsrapport '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelse28.2.2025, 08.10

Redeye: Ortoma Q4’2024 - Continued strong progress at year-end

Ortoma
Pressemeddelelse4.11.2024, 09.22

Redeye: Ortoma Q3’2024 - Positive outlook and finances in focus

Ortoma
Pressemeddelelse19.7.2024, 06.47

Redeye: Ortoma - Creating a good foundation for growth

Ortoma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Pressemeddelelse24.5.2024, 07.06

Redeye: Ortoma - Heading in the right direction

Ortoma
Pressemeddelelse21.2.2024, 07.03

Redeye: Ortoma Q4’23 - A very exciting year for Ortoma

Ortoma
Pressemeddelelse27.10.2023, 07.35

Redeye: Ortoma - Following the set path

Ortoma
Pressemeddelelse26.9.2023, 06.55

Redeye: Ortoma - A game changer

Ortoma
Pressemeddelelse23.8.2023, 12.02

Redeye: Ortoma Q2 2023 - Ignition engaged

Ortoma
Pressemeddelelse14.8.2023, 05.55

Redeye: Ortoma - Preplanning for success

Ortoma
Selskabsmeddelelse6.12.2022, 07.31

Ortoma agrees on term sheet for development and distribution of customized version of OTS Hip

Ortoma
Selskabsmeddelelse9.11.2022, 07.30

Strong interest in Ortoma's new 3D modelling concept

Ortoma
Selskabsmeddelelse7.11.2022, 08.30

Ortoma completes training session for surgeons ahead of pilot period in Japan

Ortoma
Selskabsmeddelelse31.10.2022, 09.01

Ortoma presents breakthrough 3D concept for orthopedic surgery at AAHKS Annual Meeting in Dallas

Ortoma
Selskabsmeddelelse17.3.2021, 09.24

Ortoma Submits Application for CE-mark of Spine Module

Ortoma
Selskabsmeddelelse16.3.2021, 09.47

Ortoma Obtains Granted Patent in the USA

Ortoma
Selskabsmeddelelse25.2.2021, 10.34

Ortoma launches new website highlighting market leading AI-assisted surgical solutions

Ortoma
Selskabsmeddelelse14.12.2020, 09.30

Ortoma launches OTS 5 according to plan

Ortoma
Selskabsmeddelelse12.12.2019, 09.00

Ortoma: World-class Performance with Assistance of Artificial Intelligence

Ortoma
Selskabsmeddelelse8.11.2019, 14.30

Ortoma initiates expansion with module for spine surgery

Ortoma
Selskabsmeddelelse1.7.2019, 15.19

Ortoma continues to explore market opportunities on non-exclusive basis

Ortoma
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team